Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis C, Chronic | 10 | 2019 | 973 | 1.13 | Why? |
| Ribavirin | 4 | 2018 | 1182 | 0.94 | Why? |
| Simeprevir | 2 | 2018 | 62 | 0.84 | Why? |
| Hepacivirus | 7 | 2019 | 1509 | 0.67 | Why? |
| Sofosbuvir | 2 | 2018 | 518 | 0.62 | Why? |
| Liver Cirrhosis | 6 | 2019 | 1810 | 0.59 | Why? |
| Liver Transplantation | 3 | 2020 | 2864 | 0.57 | Why? |
| Imidazoles | 1 | 2017 | 631 | 0.47 | Why? |
| Hepatitis C | 2 | 2018 | 1514 | 0.39 | Why? |
| Sustained Virologic Response | 4 | 2018 | 378 | 0.27 | Why? |
| Interferons | 1 | 2017 | 2885 | 0.27 | Why? |
| Oligopeptides | 2 | 2017 | 576 | 0.23 | Why? |
| Antiviral Agents | 12 | 2021 | 41703 | 0.21 | Why? |
| Perforin | 1 | 2020 | 136 | 0.21 | Why? |
| Iron Overload | 1 | 2021 | 113 | 0.19 | Why? |
| Valine | 2 | 2017 | 359 | 0.19 | Why? |
| Recurrence | 3 | 2018 | 3675 | 0.19 | Why? |
| alpha-Fetoproteins | 1 | 2018 | 72 | 0.18 | Why? |
| Liver Failure | 1 | 2021 | 266 | 0.17 | Why? |
| beta-Lactams | 1 | 2019 | 210 | 0.17 | Why? |
| Carbamates | 2 | 2017 | 485 | 0.17 | Why? |
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 316 | 0.16 | Why? |
| Drug Therapy, Combination | 7 | 2018 | 7268 | 0.16 | Why? |
| Organophosphonates | 1 | 2017 | 85 | 0.16 | Why? |
| RNA-Directed DNA Polymerase | 1 | 2017 | 170 | 0.16 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 552 | 0.16 | Why? |
| Therapies, Investigational | 1 | 2018 | 235 | 0.15 | Why? |
| Lamivudine | 1 | 2017 | 210 | 0.15 | Why? |
| Fibrosis | 1 | 2018 | 800 | 0.14 | Why? |
| Albumins | 1 | 2017 | 324 | 0.14 | Why? |
| Adenine | 1 | 2017 | 463 | 0.13 | Why? |
| Italy | 9 | 2021 | 38444 | 0.13 | Why? |
| Pyrrolidines | 1 | 2017 | 558 | 0.13 | Why? |
| Drug Resistance, Viral | 2 | 2017 | 1083 | 0.13 | Why? |
| Polymorphism, Genetic | 2 | 2017 | 1074 | 0.12 | Why? |
| Exosomes | 1 | 2018 | 567 | 0.11 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.11 | Why? |
| Interleukins | 1 | 2017 | 762 | 0.11 | Why? |
| Genotype | 3 | 2017 | 4697 | 0.11 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.10 | Why? |
| Hepatitis B, Chronic | 1 | 2017 | 616 | 0.10 | Why? |
| Liver | 2 | 2021 | 4007 | 0.10 | Why? |
| Hepatitis B virus | 1 | 2017 | 882 | 0.10 | Why? |
| Antimalarials | 1 | 2021 | 2505 | 0.09 | Why? |
| Bacteremia | 1 | 2019 | 1372 | 0.09 | Why? |
| Dendritic Cells | 1 | 2017 | 1330 | 0.09 | Why? |
| Rome | 2 | 2020 | 497 | 0.09 | Why? |
| Thrombophilia | 1 | 2021 | 1935 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.09 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.09 | Why? |
| Middle Aged | 20 | 2021 | 270681 | 0.08 | Why? |
| Diabetes Complications | 1 | 2019 | 2358 | 0.08 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Male | 22 | 2021 | 367725 | 0.08 | Why? |
| Aged | 17 | 2021 | 215776 | 0.07 | Why? |
| Blood Glucose | 1 | 2019 | 3642 | 0.07 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.07 | Why? |
| Female | 20 | 2021 | 380317 | 0.07 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.06 | Why? |
| Humans | 25 | 2021 | 930598 | 0.06 | Why? |
| Inflammation | 2 | 2020 | 13255 | 0.05 | Why? |
| Treatment Failure | 2 | 2017 | 2106 | 0.05 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2020 | 119 | 0.05 | Why? |
| Viral Load | 2 | 2019 | 15850 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.05 | Why? |
| Piperacillin | 1 | 2019 | 63 | 0.05 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2020 | 5397 | 0.05 | Why? |
| Renal Dialysis | 1 | 2017 | 4358 | 0.05 | Why? |
| Treatment Outcome | 7 | 2021 | 51732 | 0.05 | Why? |
| Viral Nonstructural Proteins | 1 | 2017 | 4810 | 0.05 | Why? |
| Erythrocyte Indices | 1 | 2020 | 207 | 0.05 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| Mean Platelet Volume | 1 | 2020 | 203 | 0.05 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.05 | Why? |
| Virulence Factors | 1 | 2021 | 338 | 0.05 | Why? |
| Transforming Growth Factor beta | 1 | 2020 | 363 | 0.04 | Why? |
| B7-1 Antigen | 1 | 2017 | 39 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2021 | 6543 | 0.04 | Why? |
| B7-2 Antigen | 1 | 2017 | 56 | 0.04 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.04 | Why? |
| 2-Naphthylamine | 1 | 2017 | 54 | 0.04 | Why? |
| Hepatocytes | 1 | 2021 | 549 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.04 | Why? |
| Bone Marrow | 1 | 2020 | 492 | 0.04 | Why? |
| Macrocyclic Compounds | 1 | 2017 | 78 | 0.04 | Why? |
| Uracil | 1 | 2017 | 101 | 0.04 | Why? |
| Lactams, Macrocyclic | 1 | 2017 | 130 | 0.04 | Why? |
| Serum | 1 | 2018 | 294 | 0.04 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.04 | Why? |
| Anilides | 1 | 2017 | 105 | 0.04 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.04 | Why? |
| Spleen | 1 | 2020 | 877 | 0.04 | Why? |
| Guanine | 1 | 2017 | 146 | 0.04 | Why? |
| Adult | 9 | 2021 | 244371 | 0.04 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.04 | Why? |
| Cell Communication | 1 | 2018 | 396 | 0.04 | Why? |
| Testosterone | 1 | 2021 | 596 | 0.04 | Why? |
| Iron | 1 | 2021 | 619 | 0.04 | Why? |
| Infusions, Intravenous | 1 | 2019 | 1224 | 0.04 | Why? |
| Drugs, Investigational | 1 | 2018 | 198 | 0.04 | Why? |
| Interleukin-1beta | 1 | 2020 | 992 | 0.04 | Why? |
| Sequence Analysis | 1 | 2017 | 496 | 0.04 | Why? |
| Blood Cell Count | 1 | 2020 | 1101 | 0.04 | Why? |
| Proline | 1 | 2017 | 345 | 0.04 | Why? |
| Cyclopropanes | 1 | 2017 | 332 | 0.03 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.03 | Why? |
| Liver Function Tests | 1 | 2021 | 1325 | 0.03 | Why? |
| Mitochondria | 1 | 2021 | 857 | 0.03 | Why? |
| Neutrophils | 2 | 2020 | 5476 | 0.03 | Why? |
| Spectrophotometry, Ultraviolet | 1 | 2013 | 81 | 0.03 | Why? |
| Demography | 1 | 2020 | 1660 | 0.03 | Why? |
| Tenofovir | 1 | 2017 | 449 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Drug Stability | 1 | 2013 | 236 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Polyethylene Glycols | 1 | 2017 | 574 | 0.03 | Why? |
| Positive-Pressure Respiration | 1 | 2021 | 1160 | 0.03 | Why? |
| Calibration | 1 | 2013 | 307 | 0.03 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.03 | Why? |
| Vascular Diseases | 1 | 2020 | 846 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.03 | Why? |
| Kinetics | 1 | 2019 | 3238 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Interferon-gamma | 1 | 2020 | 2711 | 0.03 | Why? |
| Drug Monitoring | 1 | 2018 | 1408 | 0.03 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2013 | 669 | 0.02 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Blood Chemical Analysis | 1 | 2013 | 541 | 0.02 | Why? |
| Reference Standards | 1 | 2013 | 1163 | 0.02 | Why? |
| Interferon-alpha | 1 | 2017 | 1442 | 0.02 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.02 | Why? |
| Survivors | 1 | 2020 | 2619 | 0.02 | Why? |
| Peptides | 1 | 2020 | 2513 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Sulfonamides | 1 | 2017 | 1294 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.02 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.02 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Limit of Detection | 1 | 2013 | 2698 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Surgical Procedures, Operative | 1 | 2020 | 2662 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2017 | 3691 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Ritonavir | 1 | 2017 | 4212 | 0.01 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
D'Offizi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(182)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(387)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_